Current Perspectives of Anticoagulation in Patients With COVID-19

被引：17
作者：
Gavioli, Elizabeth M. [1 ]
Sikorska, Gabriela [1 ]
Man, Ammy [1 ]
Rana, Jay [1 ]
Vider, Etty [1 ,2 ]
机构：
[1] Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Div Pharm, Brooklyn, NY USA
[2] Brookdale Hosp, Med Ctr, Div Pharm, Brooklyn, NY USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2020年 / 76卷 / 02期
关键词：
SARS-CoV-2; COVID-19; thromboembolism; anticoagulation; MANAGEMENT; DISEASE;
D O I：
10.1097/FJC.0000000000000861
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism and myocardial injury is common in patients with COVID-19. Low-molecular-weight heparin appears to be associated with a good prognosis in patients with COVID-19 and has the ability to reduce coagulation and inflammation markers. Hospitalized patients with COVID-19 should be placed on thromboprophylaxis with the option of full therapeutic anticoagulation or tissue plasminogen activator in high-risk or mechanically ventilated patients. Thromboprophylaxis should also be considered at hospital discharge for high-risk patients. Clinical judgment should be used to evaluate the bleeding and safety risk of anticoagulation in patients with COVID-19 without confirmed data.
引用
收藏
页码：146 / 150
页数：5
相关论文
共 50 条
  • [41] Online Search Trends Influencing Anticoagulation in Patients With COVID-19: Observational Study
    Worrall, Amy P.
    Kelly, Claire
    O'Neill, Aine
    O'Doherty, Murray
    Kelleher, Eoin
    Cushen, Anne Marie
    McNally, Cora
    McConkey, Samuel
    Glavey, Siobhan
    Lavin, Michelle
    de Barra, Eoghan
    [J]. JMIR FORMATIVE RESEARCH, 2021, 5 (08)
  • [42] Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support
    Trigonis, Russell
    Smith, Nikki
    Porter, Shelley
    Anderson, Eve
    Jennings, Mckenna
    Kapoor, Rajat
    Hage, Chadi
    Moiz, Salwa
    Garcia, Jose
    Rahman, Omar
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (02) : 414 - 418
  • [43] Use of Systemic Anticoagulation in COVID-19: Delving Beyond Theoretical Hypothesis
    Millet, Christopher
    Narvaneni, Spandana
    Shafeek, Fady
    Roman, Sherif
    Mechineni, Ashesha
    Manickam, Rajapriya
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [44] Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study
    Poulakou, Garyphallia
    Dimakakos, Evangelos
    Kollias, Anastasios
    Kyriakoulis, Konstantinos G.
    Rapti, Vasiliki
    Trontzas, Ioannis
    Thanos, Charalampos
    Abdelrasoul, Mahmoud
    Vantana, Theodora
    Leontis, Konstantinos
    Kakalou, Eleni
    Argyraki, Katerina
    Baraboutis, Ioannis
    Michelakis, Evangelos
    Giamarellos-Bourboulis, Evangelos
    Dimakou, Katerina
    Tsoukalas, Georgios
    Rapti, Angeliki
    Michelakis, Evangelos D.
    Syrigos, Konstantinos N.
    [J]. IN VIVO, 2021, 35 (01): : 653 - 661
  • [45] Current treatment challenges in the COVID-19 pandemic
    Patrucco, Filippo
    Gavelli, Francesco
    Fagoonee, Sharmila
    Solidoro, Paolo
    Undas, Anetta
    Pellicano, Rinaldo
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (09): : 854 - 861
  • [46] Perspectives of Ketamine Use in COVID-19 Patients
    Weinbroum, Avi A.
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (04)
  • [47] Curative anticoagulation prevents endothelial lesion in COVID-19 patients
    Khider, Lina
    Gendron, Nicolas
    Goudot, Guillaume
    Chocron, Richard
    Hauw-Berlemont, Caroline
    Cheng, Charles
    Rivet, Nadia
    Pere, Helene
    Roffe, Ariel
    Clerc, Sebastien
    Lebeaux, David
    Debuc, Benjamin
    Veyer, David
    Rance, Bastien
    Gaussem, Pascale
    Bertil, Sebastien
    Badoual, Cecile
    Juvin, Philippe
    Planquette, Benjamin
    Messas, Emmanuel
    Sanchez, Olivier
    Hulot, Jean-Sebastien
    Diehl, Jean-Luc
    Mirault, Tristan
    Smadja, David M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2391 - 2399
  • [48] Patterns of Prophylactic Anticoagulation Among Patients Hospitalized for COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry
    Lopes, Mathew S.
    Li, Hsin-Fang
    Sorensen, Reed J. D.
    Das, Sandeep
    Bradley, Steven M.
    de Lemos, James A.
    Roth, Gregory A.
    Wang, Tracy
    Bohula, Erin A.
    Gluckman, Ty J.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (05):
  • [49] Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review
    Hayiroglu, Mert Ilker
    Cinar, Tufan
    Tekkesin, Ahmet Ilker
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (06): : 842 - 848
  • [50] COVID-19: another reason for anticoagulation in patients with atrial fibrillation
    Raatikainen, Pekka
    Lassila, Riitta
    [J]. HEART, 2022, 108 (12) : 902 - 904
12345